Optic is an AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validation.
Optic has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Optic's investors include Kleiner Perkins, Circle, Polygon, Greylock, Davidovs Venture Collective.
Optic is headquartered in San Francisco, United States.
Optic is an AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validation.
Optic is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Optic — Funding & Investors." VCBacked, April 10, 2025, https://www.vcbacked.co/company/optic. Accessed October 30, 2026.
VCBacked. (2025). Optic — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/optic
{{cite web |title=Optic — Funding & Investors |url=https://www.vcbacked.co/company/optic |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated